Ann Partridge, MD, MPH, is a medical oncologist specializing in breast and women’s oncology, with a focus on care delivery for adolescent and young adult patients. She serves as Chief Clinical Strategy Officer and Vice Chair of Medical Oncology at Dana-Farber Cancer Institute and is a Professor of Medicine at Harvard Medical School. Her clinical work centers on young adult oncology, breast oncology, and long-term survivorship care, including supportive care needs across treatment and recovery. Her research interests include survivorship and patient-reported outcomes, fertility preservation and reproductive health in oncology, and age-related differences in tumor biology and genomics. Dr. Partridge is the founder and director of Dana-Farber’s Young and Strong program and has held key leadership roles in national and international oncology organizations, including service with ASCO, the NCI Alliance for Clinical Trials in Oncology, and Susan G. Komen. Her honors include the ESMO Award, the ASCO Ellen L. Stovall Award for Advancement of Cancer Survivorship Care, the AACR Outstanding Investigator Award for Breast Cancer, and a U.S. White House Champions of Change Award. She earned her MD from Weill Cornell Medical College, an MPH from the Harvard T.H. Chan School of Public Health, completed an internal medicine residency at the Hospital of the University of Pennsylvania, and trained in hematology and medical oncology at Dana-Farber Cancer Institute/Partners CancerCare.
Professor
Medical School
1991 – 1995
Residency
1995 – 1998
Fellowship
1998 – 2001